Published June 24, 2023 | Version v1
Journal article Open

Oral Submucous Fibrosis: Clinical Stage, Functional Stage and Histopathological Grade Correlation

  • 1. Bhabha dental college, bhopal
  • 2. NIMS Dental College and Hospital, NIMS University Rajasthan
  • 3. Thai Moogambigai Dental College and Hospital, Chennai

Description

Background- Oral submucosal fibrosis (OSMF) is a common precancerous condition predominantly
affecting the oral cavity. There are several contributing factors to its pathogenesis, areca nut chewing
being the primary culprit. OSMF reversal is difficult once the disease sets in. Hence, after its diagnosis,
staging becomes imperative as it affects the treatment plan. Several classification methods have been
developed by various authors to categorize the disease based on its clinical, functional, and
Histopathological characteristics. The main aim to conduct this study was to correlate clinical and
histopathological staging.
Materials & Methods- This study involved 30 patients who had been diagnosed with OSMF both
Clinically and Histopathologically. All 30 patients were classified and were categorized according to
their clinical and functional stages after inspection. Following this, histopathological grading was done.
Results- The statistical analysis showed that there was a wide similarity between the clinical and
functional staging. However, no significant similarity or correlation was found between the clinical and
functional staging with its corresponding histopathological grades.
Conclusions- Our study concluded that there is strong correlation between clinical and functional
grading.

Files

2.pdf

Files (495.5 kB)

Name Size Download all
md5:d4f113123fff85d2955c01c09b0b9549
495.5 kB Preview Download

Additional details

References

  • 1. Rajalalitha P, Vali S. Molecular pathogenesis of oral submucous fibrosis – A collagen metabolic disorder. J Oral Pathol Med. 2005;34:321–8. 2. Schwartz J. Demonstrated at the 11th International Dental Congress. London: 1952. Atrophiaidiopathica (tropica) mucosa oris. 3. Cox SC, Walker DM. Oral submucous fibrosis.A review. Aust Dent J. 1996;41:294–9. 4. Joshi SG. Submucous fibrosis of the palate and pillars. Indian J Otolaryngol. 1953;4:1–4. 5. Seedat HA, van Wyk CW. Betel-nut chewing and submucous fibrosis in Durban. S Afr Med J. 1998;74:568–71. 6. Tilakaratne WM, Klinikowski MF, Saku T, Peters TJ, Warnakulasuriya S. Oral submucous fibrosis: Review
  • on aetiology and pathogenesis. Oral Oncol. 2006;42:561–8. 7. World Health Organization: International Agency for Research on Cancer. Monographs on the evaluation of carcinogenic risks to humans: Betel quid and areca-nut chewing and some areca-nut-derived nitrosamines. IARC Monogr Eval Carcinog Risks Hum. 2004; 85: 1–334. 8. Ranganathan K, Uma Devi M, Joshua E, Kumar K, Saraswathi TR. Oral submucous fibrosis: A case control study in Chennai South India. J Oral Pathol Med. 2004;33:274–7. 9. Arakeri G, Brennan PA. Oral submucous fibrosis: An overview of the aetiology, pathogenesis, classification, and principles of management. Br J Oral Maxillofac Surg. 2013;51:587–93. 10. Angadi PV, Rao S. Management of oral submucous fibrosis: An overview. Oral Maxillofac Surg. 2010;14:133–42. 11. Warnakulasuriya KA, Trivedy C, Maher R, Johnson NW. Aetiology of oral submucous fibrosis. Oral Dis. 1997;3:286–7. 12. Sinor PN, Gupta PC, Murti PR, Bhonsle RB, Daftary DK, Mehta FS, et al. A case-control study of oral submucous fibrosis with special reference to the etiologic role of areca nut. J Oral Pathol Med. 1990;19:94–8. 13. Berwal V, Khangwal M, Solanki R, Khandeparker R, Savant K, Shetye O, et al. Classification systems for oral submucous fibrosis- from past to present: A review. Int J Dent Health Sci. 2014;1:900–13. 14. Pundir S, Saxena S, Aggrawal P. Oral submucous fibrosis: A disease with malignant potential: A report of two cases. J Clin Exp Dent. 2010;2(4):215–18. 15. More C, Thakkar K. Oral submucous fibrosis.An insight. J Pearldent. 2010;1:35–43. 16. Khanna JN, Andrade NN. Oral submucous fibrosis: A new concept in surgical management.Report of 100 cases. Int J Oral Maxillofac Surg. 1995;24:433–9. 17. Neville, Damm, Allen and Bouquot: Oral and Maxillofacial Pathology, Third Edition Pg 401 18. Biradar SB, Munde AD, Biradar BC, Shaik SS, Mishra S . O r a l s u b m u c o u s f i b r o s i s : A c l i n i c o - histopathological correlational study. J Cancer Res Ther. 2018;14:597–603. 19. Pandya S, Chaudhary AK, Singh M, Singh M, Mehrotra R. Correlation of histopathological diagnosis with habits and clinical findings in oral submucous fibrosis. Head Neck Oncol. 2009;1:10. 20. Radhika T, Sekaran P, Narshimhan M. Qualitative analysis of collagen fibres in oral submucous fibrosis using picrosirius red stain and polarizing microscope. J Clin Diag Res. 2016;10:ZC04–7. 21. Shivakumar G, Sahana S. Correlation between the functional and histological staging of oral submucous fibrosis. J Indian Acad Oral Med Radiol. 2010;22: 133–5. 22. Goel S, Ahmed J, Singh MP, Nahar P. Oral submucous
  • fibrosis: A clinico-histopathological comparative study in population of Southern Rajasthan. J Carcinog Mutagen. 2010;1:108. 23. Bhatt P, Manjunath M, Khakhla D, Gubrellay P, Bhargava R, Guruprasad L. Assessment and correlation between functional and histological staging of oral submucous fibrosis: A clinicohistopathologic study. Natl J Maxillofac Surg. 2019;10:27–32.